Veröffentlichungen

Schmitt, J., Klinkhammer-Schalke, M., Bierbaum, V., Gerken, M., Bobeth, C., Rößler, M., Dröge, P., Ruhnke, T., Günster, C., Kleihues-van Tol, K., Schoffer, O., WiZen Study Group, 2023b. Initial Cancer Treatment in Certified Versus Non-Certified Hospitals. Dtsch Arztebl Int 120, 647–654.

Spoerl, Steffen, Erber, R., Gerken, M., Taxis, J., Ludwig, N., Nieberle, F., Biermann, N., Geppert, C.I., Ettl, T., Hartmann, A., Beckhove, P., Reichert, T.E., Spanier, G., Spoerl, Silvia, 2023a. A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma. Cancers (Basel) 15, 675.

Spoerl, Steffen, Gerken, M., Fischer, R., Spoerl, Silvia, Kirschneck, C., Wolf, S., Taxis, J., Ludwig, N., Biermann, N., Reichert, T.E., Spanier, G., 2023b. Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma-Data from a Population-Based Cohort Study Applying Propensity Score Matching. Biomedicines 11, 369.

Teufel, A., Meindl-Beinker, N.M., Hösel, P., Gerken, M., Roig, A., Ebert, M.P., Herr, W., Scheiter, A., Pauer, A., Schlitt, H.J., Klinkhammer-Schalke, M., 2023. Characteristics and outcome of patients with small bowel adenocarcinoma (SBA). J Cancer Res Clin Oncol 149, 4579–4590.

van Maaren, M.C., Hueting, T.A., Völkel, V., van Hezewijk, M., Strobbe, L.J., Siesling, S., 2023. The use and misuse of risk prediction tools for clinical decision-making. Breast 69, 428–430.

Hatzipanagiotou, M. E., Pigerl, M.C., Gerken, M., Raepple, S., Zeltner, V., Ugocsai, P., Ortmann, O., Klinkhammer-Schalke, M., Seitz, S., 2023b. Influence of the Time Interval until the Start of adjuvant Chemotherapy on Overall Survival in Patients with triple-negative Breast Cancer. Geburtshilfe Frauenheilkd. 83, 739–740.

Hintschich, C.A., Gerken, M., Spoerl, S., Bohr, C., Künzel, J., 2023. Primary Diagnoses of Squamous Cell Carcinoma of the Head and Neck During the COVID-19 Pandemic. Dtsch Arztebl Int 120, 719–720.

Kim-Wanner, S.-Z., Sackmann, A., Neuser, P., Kleihues-van Tol, K., Klinkhammer-Schalke, M., Papathemelis, T., 2023. Minimal invasive surgery in endometrial carcinoma in Germany 2000-2020-a population based study. Oncol. Res. Treat. 46, 150–151.

Röhrmoser, K., Ignatov, A., Gerken, M., Ortmann, O., Klinkhammer-Schalke, M., Papathemelis, T., 2023. Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration. J Cancer Res Clin Oncol 149, 803–810.

Scharl, S., Sprötge, T., Gerken, M., Scharl, A., Ortmann, O., Kölbl, O., Klinkhammer-Schalke, M., Papathemelis, T., 2023. Guideline concordant therapy improves survival in high-grade endometrial cancer patients. J Cancer Res Clin Oncol 149, 4761–4769.

Schmitt, J., Bierbaum, T., Geraedts, M., Gothe, H., Härter, M., Hoffmann, F., Ihle, P., Kramer, U., Klinkhammer-Schalke, M., Kuske, S., March, S., Reese, J.-P., Schoffer, O., Swart, E., Vollmar, H.C., Walther, F., Hoffmann, W., 2023a. The Health Data Utilization Act – potential for better research and  health care. Gesundheitswesen 85, 215–222.

Klinkhammer-Schalke, M., Wesselmann, S., Bruns, J., Nettekoven, G., Tillack, A., Follmann, M., Arndt, V., Graeven, U., Hartz, T., Illmer, T., Inwald, E.C., Kaiser, T., Nothacker, M., Ortmann, O., Schmidt, S., Schmitt, J., Zeissig, S.R., Seufferlein, T., 2023. [Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]. Gesundheitswesen 85, 649–656.

Meyer, S., Buser, L., Haferkamp, S., Berneburg, M., Maisch, T., Klinkhammer-Schalke, M., Pauer, A., Vogt, T., Garbe, C., 2023. Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma. Eur J Cancer 182, 77–86.

Petruch, N., Servin Rojas, M., Lillemoe, K.D., Castillo, C.F.-D., Braun, R., Honselmann, K.C., Lapshyn, H., Deichmann, S., Abdalla, T.S.A., Hummel, R., Klinkhammer-Schalke, M., Tol, K.K., Zeissig, S.R., Keck, T., Wellner, U.F., Qadan, M., Bolm, L., 2023. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries. Surgery S0039-6060(23)00844–9.

Scheiter, Alexander, Hierl, F., Lüke, F., Keil, F., Heudobler, D., Einhell, S., Klier-Richter, M., Konstandin, N.P., Weber, F., Scheiter, Andrea, Kandulski, A., Schlosser, S., Cosma, L.-S., Tews, H., Weiss, A.R.R., Grube, M., Bumes, E., Hau, P., Proescholdt, M., Steger, F., Troeger, A., Haferkamp, S., Reibenspies, L.E., Schnabel, M.J., Schulz, C., Drexler, K., Hatzipanagiotou, M.E., Seitz, S., Klinkhammer-Schalke, M., Unberath, P., Calvisi, D.F., Pukrop, T., Dietmaier, W., Evert, M., Utpatel, K., 2023. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. Br J Cancer 128, 1134–1147.

Bierbaum, T., Dreinhöfer, K., Klinkhammer-Schalke, M., Schmitt, J., 2023. [Register-based research and clinical studies : Possibilities, limitations and perspectives]. Orthopadie (Heidelb) 52, 447–454.

Bierbaum, V., Schmitt, J., Klinkhammer-Schalke, M., Schoffer, O., 2023. Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis. Gesundheitswesen 85, S197–S204.

Bobeth, C., Tol, K.K., Rößler, M., Bierbaum, V., Gerken, M., Günster, C., Dröge, P., Ruhnke, T., Klinkhammer-Schalke, M., Schmitt, J., Schoffer, O., 2023. [Methodology and Attribution Success of a Data Linkage of Clinical Registry Data with Health Insurance Data]. Gesundheitswesen 85, S154–S161.

Bohne, Annika, Grundler, E., Knüttel, H., Fürst, A., Völkel, V., 2023. Influence of Laparoscopic Surgery on Cellular Immunity in Colorectal Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) 15, 3381.

Bohne, A., Grundler, E., Knüttel, H., Völkel, V., Fürst, A., 2023. Impact of laparoscopic versus open surgery on humoral immunity in patients with colorectal cancer: a systematic review and meta-analysis. Surg Endosc.

Hatzipanagiotou, M. E., Pigerl, M., Gerken, M., Raepple, S., Zeltner, V., Hetterich, M., Ugocsai, P., Inwald, E.C., Klinkhammer-Schalke, M., Ortmann, O., Seitz, S., 2023a. Effects of delaying adjuvant chemotherapy initiation on clinical outcomes in early triple-negative breast cancer patients. Ann. Oncol. 34, S285–S285.

Fernández-Pacheco, M., Gerken, M., Ortmann, O., Ignatov, A., Klinkhammer-Schalke, M., Hatzipanagiotou, M.E., Inwald, E.C., 2023. Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery. Arch Gynecol Obstet 307, 1573–1583.

Fischl, A., Gerken, M., Roos, P., Haedenkamp, T., Hillberg, A., Klinkhammer-Schalke, M., Kölbl, O., Linker, R., Proescholdt, M., Pukrop, T., Riemenschneider, M.J., Schmidt, N.O., Schön, I., Vogelhuber, M., Hau, P., Bumes, E., 2023. Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study. Neurooncol Pract 10, 446–453.

Graf, M., Gerken, M., Klinkhammer-Schalke, M., Schrodi, S., Engel, J., Pauer, A., Ortmann, O., Inwald, E.C., 2023. Comparison of clinical, histopathological, therapeutic Factors and Survival between 2510 male and 307634 female Patients with malignant Breast Neoplasms – Results of a large population-based Cohort Study in Germany. Geburtshilfe Frauenheilkd. 83, 739–739.

Hatzipanagiotou, Maria Eleni, Pigerl, M., Gerken, M., Räpple, S., Zeltner, V., Hetterich, M., Ugocsai, P., Fernandez-Pacheco, M., Inwald, E.C., Klinkhammer-Schalke, M., Ortmann, O., Seitz, S., 2023. Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer? J Cancer Res Clin Oncol 149, 11941–11950.

Abdalla, T.S.A., Klinkhammer-Schalke, M., Zeissig, S.R., Tol, K.K., Honselmann, K.C., Braun, R., Bolm, L., Lapshyn, H., Litkevych, S., Zemskov, S., Begum, N., Kulemann, B., Hummel, R., Wellner, U.F., Keck, T., Deichmann, S., 2023a. Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers. J Cancer Res Clin Oncol 149, 8535–8543.

Abdalla, T.S.A., Pieper, L., Kist, M., Thomaschewski, M., Klinkhammer-Schalke, M., Zeissig, S.R., Tol, K.K., Wellner, U.F., Keck, T., Hummel, R., 2023b. Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group. J Cancer Res Clin Oncol 149, 7461–7469.

Acs, M., Gerken, M., Schmitt, V., Piso, P., Königsrainer, A., Baransi, S., Yurttas, C., Häusler, S., Horvath, P., 2023a. Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS. Cancers (Basel) 15, 405.

Acs, M., Gerken, M., Zustin, J., Blaj, S., Isgandarova, S., Piso, P., 2023b. Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Surg Res 283, 839–852.